MedPath

Med-Life Discoveries LP

Med-Life Discoveries LP logo
🇨🇦Canada
Ownership
Holding
Established
2015-01-01
Employees
1
Market Cap
-
Website
http://www.med-life.ca

A First-in-Human Phase 1 Study of Plasmalogen Precursor PPI-1011 in Healthy Adult Volunteers to Assess Safety, Tolerability, and Pharmacokinetics

Phase 1
Recruiting
Conditions
Rhizomelic Chondrodysplasia Punctata
Interventions
Drug: Placebo
First Posted Date
2023-08-01
Last Posted Date
2023-08-01
Lead Sponsor
MED-LIFE DISCOVERIES LP
Target Recruit Count
56
Registration Number
NCT05969977
Locations
🇨🇦

Biopharma Services Inc., Toronto, Ontario, Canada

RCDP Natural History Study

Conditions
Rhizomelic Chondrodysplasia Punctata
First Posted Date
2019-07-24
Last Posted Date
2019-08-02
Lead Sponsor
MED-LIFE DISCOVERIES LP
Target Recruit Count
75
Registration Number
NCT04031287
Locations
🇺🇸

Alfred I. DuPont Hospital for Children, Wilmington, Delaware, United States

© Copyright 2025. All Rights Reserved by MedPath